Moderna Seeks Authorization of Booster for Adults 18 and Over

Moderna said it filed for FDA Emergency Use Authorization of its Covid-19 booster for all adults ages 18 and older.

NOTE

• Pfizer, BioNTech Up on Report FDA May Give Booster Nod Thursday
• Moderna Inc. rose 5.09% to USD246 as of 1:23 p.m. New York time
  • The average 12-month price target of $286 is 16% above the current price
  • 9 buys, 5 sells, 5 holds

To view the source of this information, click here

To contact the reporter on this story:
Greg Chang in San Francisco at gchang1@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© ...